Citi raised the firm’s price target on Corteva (CTVA) to $70 from $68 and keeps a Neutral rating on the shares. The firm updated estimates and targets in the chemicals group as part of its 2026 outlook. Citi is more negative on polyethylene producers and more positive on lithium fundamentals heading into next year.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTVA:
- Corteva, Hexagon Bio enter multi-million-dollar crop protection joint venture
- Corteva’s Growth Potential Bolstered by Strategic Collaborations and Legal Developments
- Corteva assumed with an Overweight at Wells Fargo
- Corteva price target raised to $76 from $75 at Oppenheimer
- Corteva’s Strategic Adjustments and Strong Crop Protection Performance Drive Buy Rating